The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors

被引：122

作者：

Bellone, Matteo ^{[1
]}

Calcinotto, Arianna ^{[1
]}

Filipazzi, Paola ^{[2
]}

De Milito, Angelo ^{[3
,4
]}

Fais, Stefano ^{[3
]}

Rivoltini, Licia ^{[2
]}

机构：

[1] Ist Sci San Raffaele, Cellular Immunol Unit, I-20132 Milan, Italy

[2] Fdn IRCCS Ist Nazl Tumori, Unit Immunotherapy Human Tumors, Milan, Italy

[3] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Unit Antitumor Drugs, I-00161 Rome, Italy

[4] Karolinska Inst, Canc Ctr Karolinska, Stockholm, Sweden

来源：

ONCOIMMUNOLOGY | 2013年 / 2卷 / 01期

关键词：

anergy; T cell; melanoma; prostate cancer; adoptive immunotherapy; active immunotherapy; CELLS;

D O I：

10.4161/onci.22058

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We have recently reported that lowering the pH to values that are frequently detected in tumors causes reversible anergy in both human and mouse CD8(+) T lymphocytes in vitro. The same occurs in vivo, in the tumor microenvironment and the administration of proton pump inhibitors, which buffer tumor acidity, can revert T-cell anergy and increase the efficacy of immunotherapy.

引用

页数：3

共 10 条

[1] Regulation of cancer cell metabolism [J].

Cairns, Rob A. ;

Harris, Isaac S. ;

Mak, Tak W. .

NATURE REVIEWS CANCER, 2011, 11 (02) :85-95

[2] Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes [J].

Calcinotto, Arianna ;

Filipazzi, Paola ;

Grioni, Matteo ;

Iero, Manuela ;

De Milito, Angelo ;

Ricupito, Alessia ;

Cova, Agata ;

Canese, Rossella ;

Jachetti, Elena ;

Rossetti, Monica ;

Huber, Veronica ;

Parmiani, Giorgio ;

Generoso, Luca ;

Santinami, Mario ;

Borghi, Martina ;

Fais, Stefano ;

Bellone, Matteo ;

Rivoltini, Licia .

CANCER RESEARCH, 2012, 72 (11) :2746-2756

[3] Inhibitory effect of tumor cell-derived lactic acid on human T cells [J].

Fischer, Karin ;

Hoffmann, Petra ;

Voelkl, Simon ;

Meidenbauer, Norbert ;

Ammer, Julia ;

Edinger, Matthias ;

Gottfried, Eva ;

Schwarz, Sabine ;

Rothe, Gregor ;

Hoves, Sabine ;

Renner, Kathrin ;

Timischl, Birgit ;

Mackensen, Andreas ;

Kunz-Schughart, Leoni ;

Andreesen, Reinhard ;

Krause, Stefan W. ;

Kreutz, Marina .

BLOOD, 2007, 109 (09) :3812-3819

[4] Why do cancers have high aerobic glycolysis? [J].

Gatenby, RA ;

Gillies, RJ .

NATURE REVIEWS CANCER, 2004, 4 (11) :891-899

[5] Relevance of tumor microenvironment for progression, therapy and drug development [J].

Henning, T ;

Kraus, M ;

Brischwein, M ;

Otto, AM ;

Wolf, B .

ANTI-CANCER DRUGS, 2004, 15 (01) :7-14

[6]

Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522

[7] Proton pump inhibitors: actions and reactions [J].

Mullin, James M. ;

Gabello, Melissa ;

Murray, Lisa J. ;

Farrell, Christopher P. ;

Bellows, Jillan ;

Wolov, Kevin R. ;

Kearney, Keith R. ;

Rudolph, David ;

Thornton, James J. .

DRUG DISCOVERY TODAY, 2009, 14 (13-14) :647-660

[8] A proton-pump inhibitor expedition: The case histories of omeprazole and esomeprazole [J].

Olbe, L ;

Carlsson, E ;

Lindberg, P .

NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (02) :132-139

[9] Immunosuppressive strategies that are mediated by tumor cells [J].

Rabinovich, Gabriel A. ;

Gabrilovich, Dmitry ;

Sotomayor, Eduardo M. .

ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :267-296

[10] Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host Implication in antitumor activation of tumor-associated macrophages [J].

Vishvakarma, Naveen Kumar ;

Singh, Sukh Mahendra .

IMMUNOLOGY LETTERS, 2010, 134 (01) :83-92

← 1 →